Published in Health Business Week, August 14th, 2009
"It is a great pleasure to welcome John to our team," said Staph Leavenworth Bakali, Genocea's Chief Executive Officer. "John's extensive experience in business development and track record of success will be of great value to Genocea's partnering and business development activities."
"Genocea has developed one of the most exciting approaches to vaccine discovery and is accelerating vaccine development in multiple multi-billion dollar market segments," said Dr. Sorvillo. "I...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.